1. Home
  2. TSHA vs LZB Comparison

TSHA vs LZB Comparison

Compare TSHA & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$5.04

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$39.21

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSHA
LZB
Founded
2019
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
TSHA
LZB
Price
$5.04
$39.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
2
Target Price
$10.56
$42.50
AVG Volume (30 Days)
3.4M
481.3K
Earning Date
02-25-2026
02-17-2026
Dividend Yield
N/A
2.57%
EPS Growth
N/A
N/A
EPS
N/A
2.16
Revenue
$6,310,000.00
$2,107,357,000.00
Revenue This Year
N/A
$2.36
Revenue Next Year
N/A
$3.57
P/E Ratio
N/A
$17.45
Revenue Growth
N/A
1.78
52 Week Low
$1.05
$29.03
52 Week High
$6.02
$48.31

Technical Indicators

Market Signals
Indicator
TSHA
LZB
Relative Strength Index (RSI) 45.54 61.55
Support Level $4.80 $37.00
Resistance Level $5.69 $38.09
Average True Range (ATR) 0.31 0.82
MACD -0.11 -0.15
Stochastic Oscillator 18.44 74.50

Price Performance

Historical Comparison
TSHA
LZB

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

Share on Social Networks: